Annual Total Expenses
$103.66 M
-$7.83 M-7.02%
31 December 2023
Summary:
Aligos Therapeutics annual total expenses is currently $103.66 million, with the most recent change of -$7.83 million (-7.02%) on 31 December 2023. During the last 3 years, it has fallen by -$29.02 million (-21.88%). ALGS annual total expenses is now -21.88% below its all-time high of $132.68 million, reached on 31 December 2021.ALGS Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$21.40 M
-$6.08 M-22.11%
30 September 2024
Summary:
Aligos Therapeutics quarterly total expenses is currently $21.40 million, with the most recent change of -$6.08 million (-22.11%) on 30 September 2024. Over the past year, it has dropped by -$7.28 million (-25.38%). ALGS quarterly total expenses is now -44.15% below its all-time high of $38.31 million, reached on 31 December 2021.ALGS Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALGS Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -25.4% |
| 3 y3 years | -21.9% | -44.1% |
| 5 y5 years | +91.8% | +16.1% |
ALGS Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -21.9% | at low | -44.1% | at low |
| 5 y | 5 years | -21.9% | +91.8% | -44.1% | +16.1% |
| alltime | all time | -21.9% | +91.8% | -44.1% | +47.5% |
Aligos Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $21.40 M(-22.1%) |
| June 2024 | - | $27.48 M(+19.3%) |
| Mar 2024 | - | $23.03 M(-19.7%) |
| Dec 2023 | $103.66 M(-7.0%) | $28.68 M(+28.5%) |
| Sept 2023 | - | $22.31 M(-14.3%) |
| June 2023 | - | $26.03 M(-2.3%) |
| Mar 2023 | - | $26.64 M(+1.6%) |
| Dec 2022 | $111.49 M | $26.22 M(+13.7%) |
| Sept 2022 | - | $23.05 M(-4.3%) |
| June 2022 | - | $24.09 M(-36.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $38.13 M(-0.5%) |
| Dec 2021 | $132.68 M(+35.6%) | $38.31 M(+10.7%) |
| Sept 2021 | - | $34.60 M(+11.2%) |
| June 2021 | - | $31.11 M(+8.6%) |
| Mar 2021 | - | $28.65 M(-16.4%) |
| Dec 2020 | $97.83 M(+81.0%) | $34.29 M(+59.0%) |
| Sept 2020 | - | $21.56 M(+1.3%) |
| June 2020 | - | $21.27 M(+2.7%) |
| Mar 2020 | - | $20.72 M(+12.4%) |
| Dec 2019 | $54.04 M | $18.44 M(+27.1%) |
| Sept 2019 | - | $14.50 M |
FAQ
- What is Aligos Therapeutics annual total expenses?
- What is the all time high annual total expenses for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly total expenses year-on-year change?
What is Aligos Therapeutics annual total expenses?
The current annual total expenses of ALGS is $103.66 M
What is the all time high annual total expenses for Aligos Therapeutics?
Aligos Therapeutics all-time high annual total expenses is $132.68 M
What is Aligos Therapeutics quarterly total expenses?
The current quarterly total expenses of ALGS is $21.40 M
What is the all time high quarterly total expenses for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly total expenses is $38.31 M
What is Aligos Therapeutics quarterly total expenses year-on-year change?
Over the past year, ALGS quarterly total expenses has changed by -$7.28 M (-25.38%)